CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRLCIK 0001100682
Revenue (TTM)
$4.02B
−0.9% YoY
Q1 Apr 2026
Net Income (TTM)
$117.37M
−750.1% YoY
Q1 Apr 2026
EPS Diluted (TTM)
$2.36
−1,555.0% YoY
Q1 Apr 2026
Gross Margin
7.5%
Q1 Apr 2026
Operating Margin
10.7%
Q1 Apr 2026
Net Margin
2.9%
Q1 Apr 2026
Free Cash Flow (TTM)
$265.94M
Q1 Apr 2026
Cash
$191.83M
Q1 Apr 2026
Total Debt
$1.63B
Q1 Apr 2026
Shares Outstanding
48.17M sh
Q1 Apr 2026